Overview
- 6 inspections across 6 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-12-14.
At a glance
Inspections
6
Sites
6
Observations
5
Career since
Feb 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kyowa Kirin Co., Ltd. | 14 Dec 2022 | Human Drugs | On file |
| PQ Corporation | 22 Feb 2022 | Human Drugs | On file |
| Shandong Xinhua Pharmaceutical Co., Ltd. FDF Plant | 17 Jan 2020 | Human Drugs | |
| Haimen Pharma Inc. | 10 Jan 2020 | Human Drugs | On file |
| L. Perrigo Company | 22 Oct 2019 | Human Drugs | On file |
Sites inspected
Kyowa Kirin Co., Ltd.Takasaki, Japan1 insp.
PQ CorporationUtica, United States1 insp.
Shandong Xinhua Pharmaceutical Co., Ltd. FDF PlantZibo, China1 insp.
Haimen Pharma Inc.Haimen City, China1 insp.
L. Perrigo CompanyHolland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lindsey M Schwierjohann2 shared
Nibin Varghese1 shared
Cynthia Jim1 shared
Norman K Starks1 shared
Jon P Antoniou1 shared
Ying Zhang1 shared
Charles L Zhou1 shared
Full investigator report
Get the verbatim findings behind Lindsey S Fleischman's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site